Golimumab an alternative in RA
29 June 2009
| by Nicola Garrett
The new tumour necrosis factor α inhibitor golimumab could be an alternative treatment for patients with rheumatoid arthritis who have had inadequate responses to DMARDs or other TNF- α inhibitors, an international study finds....
Want to read complete article? Please Sign in or Register.